Dynamic Advisor Solutions LLC Increases Holdings in ARK Genomic Revolution ETF

On October 13, 2024, it was reported that Dynamic Advisor Solutions LLC has increased its investment in the ARK Genomic Revolution ETF (BATS:ARKG) by 7.8% in the third quarter of the year. The firm disclosed this information in its latest filing with the Securities and Exchange Commission (SEC). Following the acquisition of an additional 989 shares during the quarter, Dynamic Advisor Solutions LLC now holds a total of 13,590 shares in the ETF, which were valued at approximately $348,000 at the close of the most recent reporting period.

In addition to Dynamic Advisor Solutions LLC, several other institutional investors have also adjusted their stakes in the ARK Genomic Revolution ETF recently. For instance, First Horizon Advisors Inc. increased its position by 9.4% during the second quarter, acquiring 398 additional shares, bringing their total holdings to 4,650 shares valued at around $109,000. Similarly, Prospect Financial Services LLC raised its stake by 3.7%, obtaining an additional 500 shares, now owning 14,093 shares with a total valuation of $331,000. Furthermore, Bridges Investment Management Inc. expanded its holdings by 3.8%, purchasing an extra 517 shares to reach 14,121 shares worth $332,000.

Brown Miller Wealth Management LLC also enhanced its position in the first quarter, growing its investment by 4.4% and acquiring 714 shares for a total of 16,823 shares, valued at $483,000. SkyOak Wealth LLC made a more significant increase, boosting its holdings by 14.2%, purchasing an additional 1,000 shares to bring their total to 8,029 shares with an approximate value of $231,000.

Current Performance of ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF opened at $24.79. The fund's current performance is reflected in its 50-day and 200-day moving averages, which are $25.39 and $25.36, respectively. This data indicates a relatively stable stock price performance over a short-term and long-term period.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that primarily focuses on investing in stocks related to a specific theme. This actively managed fund targets companies operating within the genomics industry and was launched by ARK on October 31, 2014. ARKG aims to capitalize on advancements in genomic research, sequencing, and related technologies, making it an appealing option for investors interested in this rapidly evolving sector.

Investment, ETF, Shares